Turning on a certain brain receptor (called GLP-1) seems to calm down overactive immune cells in the brain and reduce inflammation in animals with diseases like Alzheimer's and Parkinson's — which might help protect brain cells.

1

Pro

0

Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

1

Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

Narrative Review

Animal

2022 Aug 24

The study looks at how activating GLP-1 receptors in the brain can calm inflammation in diseases like Alzheimer’s and Parkinson’s, which matches the claim.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

Score: 1

DOI: 10.3390/ijms23179583

Similar Assertions

Turning on a certain brain cell switch (GLP-1) seems to calm brain inflammation in mice with Alzheimer’s or multiple sclerosis, which might help slow down these diseases.

1

0

84%

A type of diabetes drug might help protect the brain in diseases like Alzheimer’s and MS by calming brain immune cells and stopping harmful changes in other brain cells.

1

0

82%